Publication | Closed Access

Comparison of rapidly cycled tandem high-dose chemotherapy plus peripheral-blood stem-cell support versus dose-dense conventional chemotherapy for adjuvant treatment of high-risk breast cancer: results of a multicentre phase III trial

Dose-dense Conventional ChemotherapyOncologyHigh-risk Breast CancerBreast OncologyTandem High-dose ChemotherapyBreast CancerCancer TreatmentMedicineRadiation Oncology